- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | RxSight, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mo | RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 | 1 | GlobeNewswire (USA) | ||
| 11.04. | Assessing RxSight: Insights From 8 Financial Analysts | 1 | Benzinga.com | ||
| 04.04. | RxSight, Inc.: RxSight Announces Commercial Launch of its Newest Light Adjustable Lens, the LAL+, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting | 1 | GlobeNewswire (USA) | ||
| 27.03. | RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 01.03. | Earnings call: RxSight reported an increase in revenue of 78% in Q4 | 1 | Investing.com | ||
| 01.03. | RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 29.02. | RxSight shares target raised to $64 on strong growth outlook | 1 | Investing.com | ||
| 29.02. | Forecasting The Future: 9 Analyst Projections For RxSight | 1 | Benzinga.com | ||
| 29.02. | Rxsight Inc reports results for the quarter ended in December - Earnings Summary | - | Reuters | ||
| 29.02. | RxSight, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 28.02. | Recap: RxSight Q4 Earnings | 1 | Benzinga.com | ||
| 28.02. | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | 133 | GlobeNewswire (Europe) | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| 28.02. | RxSight, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.02. | RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 | 1 | GlobeNewswire (USA) | ||
| 29.01. | The Analyst Landscape: 8 Takes On RxSight | 3 | Benzinga.com | ||
| 08.01. | Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session | 1 | Benzinga.com | ||
| 08.01. | RxSight shares up on prelim Q4 revenue beat | 3 | Seeking Alpha | ||
| 08.01. | RxSight gains as brokerages lift PT on upbeat prelim 2024 revenue forecast | 3 | Reuters | ||
| 08.01. | Breaking Down RxSight: 5 Analysts Share Their Views | 1 | Benzinga.com |
Seite:
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 36,300 | -0,55 % | EQS-PVR: Eckert & Ziegler SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Eckert & Ziegler SE
Eckert & Ziegler SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
19.04.2024 / 20:57 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| THERMO FISHER | 534,60 | -0,96 % | Thermo Fisher Scientific-Aktie legt um 4,16 Prozent zu (531,8757 €) | An der US-amerikanischen Börse liegt das Wertpapier von Thermo Fisher Scientific gegenwärtig im Plus. Der jüngste Kurs betrug 568,99 US-Dollar. Freuen können sich gegenwärtig die Aktionäre von Thermo... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 304,80 | +3,92 % | Align Technology Inc. Q1 Profit Increases, beats estimates | WASHINGTON (dpa-AFX) - Align Technology Inc. (ALGN) announced earnings for its first quarter that increased from the same period last year and beat the Street estimates.The company's earnings... ► Artikel lesen | |
| HIMS & HERS HEALTH | 11,480 | -0,43 % | Why Hims & Hers Stock Was Down This Week | ||
| INMODE | 16,375 | +0,89 % | InMode LTD: InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M | YOKNEAM, Israel, Feb. 13, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results... ► Artikel lesen | |
| RESMED | 171,05 | -0,44 % | ResMed Q3 2024 Earnings Preview | ||
| ORPEA | 11,894 | -4,50 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| SENSEONICS | 0,386 | -4,40 % | Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for... ► Artikel lesen | |
| NANO-X IMAGING | 9,100 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| SHOCKWAVE MEDICAL | 303,80 | -1,04 % | Shockwave Medical (SWAV) Rose on an Acquisition News and Solid Financial Result | ||
| BONESUPPORT | 19,480 | -7,06 % | BONESUPPORT HOLDING AB (publ) - Publishes year end report 2023 | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the fourth quarter 2023 and the full year 2023.
STRONG... ► Artikel lesen | |
| LANTHEUS | 60,10 | -1,35 % | Lantheus Holdings, Inc.: Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time | ||
| INSPIRE MEDICAL SYSTEMS | 215,00 | 0,00 % | The Latest Analyst Ratings For Inspire Medical Systems | ||
| BUTTERFLY NETWORK | 0,707 | 0,00 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
| TRANSMEDICS GROUP | 85,38 | +2,84 % | TransMedics Group, Inc.: TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | ANDOVER, Mass., April 8, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with... ► Artikel lesen |
Das Unternehmen RXSIGHT INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 52,84 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
